JCLA:应用电化学发光法定量测定抗分形多胺单克隆抗体E6011在猴子和人类体内的药代动力学研究

2019-05-16 不详 网络

E6011是一种人源抗fractalkine单克隆抗体,目前正用于治疗各种炎症性疾病,如类风湿关节炎。本研究建立了用电化学发光(ECL)法测定猴血清和人血清中E6011的方法。 mso-ascii-theme-font:minor-latin;mso-fareast-font-family:宋体;mso-fareast-theme-font: minor-fareast;mso-hansi-f

E6011是一种人源抗fractalkine单克隆抗体,目前正用于治疗各种炎症性疾病,如类风湿关节炎。本研究建立了用电化学发光(ECL)法测定猴血清和人血清中E6011的方法。

研究人员用fractalkine检测血清中的E6011,用钌标记的兔抗E6011 Fab多克隆抗体检测ECLE6011血清中从0.020.1可量化μg /毫升的猴子和人类的血清,最低稀释量为500。然后根据生物分析指南对该方法进行了验证。

五种浓度的质量控制样品在a‐中的准确度和精密度以及批次间重现性表明,相对误差和相对标准偏差在可接受的标准范围内。在人类和猴子中,E6011的回收率分别为92.9%121.7%85.0%109.3%。稀释完整性、无前体效应、无抗原影响。平行度也被证实使用发生的临床样本分析。对各类型稳定性进行了评价,结果表明,在冷冻条件下,E6011在猴血清中稳定367天,在人血清中可稳定735天。

研究表明,该方法已成功应用于猴子和人类的药代动力学研究。

原始出处:

Muneo Aoyama, Yuji Mano,Application of an electrochemiluminescence assay for quantification of E6011, an antifractalkine monoclonal antibody, to pharmacokinetic studies in monkeys and humans

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


 

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1764877, encodeId=eb8a1e64877c4, content=<a href='/topic/show?id=0a8f68226b7' target=_blank style='color:#2F92EE;'>#猴子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68226, encryptionId=0a8f68226b7, topicName=猴子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735537811831, createdName=ms1948154235210413, createdTime=Tue Mar 31 11:11:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662291, encodeId=69d5166229117, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Aug 24 17:11:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798727, encodeId=9b451e987274a, content=<a href='/topic/show?id=c23fe0014b1' target=_blank style='color:#2F92EE;'>#电化学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70014, encryptionId=c23fe0014b1, topicName=电化学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Aug 07 02:11:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775142, encodeId=db381e7514238, content=<a href='/topic/show?id=c05b43411ef' target=_blank style='color:#2F92EE;'>#多胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43411, encryptionId=c05b43411ef, topicName=多胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1538755075, createdName=waiwai3043, createdTime=Sat Apr 18 19:11:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666729, encodeId=8c9f1666e29cc, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Sep 18 11:11:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660191, encodeId=a00e16601914e, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28912, encryptionId=8d0d28912db, topicName=克隆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596825099872, createdName=aids221, createdTime=Wed Sep 25 00:11:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351272, encodeId=f1b713512e282, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87289, encryptionId=9ac28e2893e, topicName=药代动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 18 11:11:00 CST 2019, time=2019-05-18, status=1, ipAttribution=)]
    2020-03-31 ms1948154235210413

    #猴子#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1764877, encodeId=eb8a1e64877c4, content=<a href='/topic/show?id=0a8f68226b7' target=_blank style='color:#2F92EE;'>#猴子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68226, encryptionId=0a8f68226b7, topicName=猴子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735537811831, createdName=ms1948154235210413, createdTime=Tue Mar 31 11:11:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662291, encodeId=69d5166229117, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Aug 24 17:11:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798727, encodeId=9b451e987274a, content=<a href='/topic/show?id=c23fe0014b1' target=_blank style='color:#2F92EE;'>#电化学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70014, encryptionId=c23fe0014b1, topicName=电化学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Aug 07 02:11:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775142, encodeId=db381e7514238, content=<a href='/topic/show?id=c05b43411ef' target=_blank style='color:#2F92EE;'>#多胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43411, encryptionId=c05b43411ef, topicName=多胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1538755075, createdName=waiwai3043, createdTime=Sat Apr 18 19:11:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666729, encodeId=8c9f1666e29cc, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Sep 18 11:11:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660191, encodeId=a00e16601914e, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28912, encryptionId=8d0d28912db, topicName=克隆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596825099872, createdName=aids221, createdTime=Wed Sep 25 00:11:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351272, encodeId=f1b713512e282, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87289, encryptionId=9ac28e2893e, topicName=药代动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 18 11:11:00 CST 2019, time=2019-05-18, status=1, ipAttribution=)]
    2019-08-24 爆笑小医

    #测定#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1764877, encodeId=eb8a1e64877c4, content=<a href='/topic/show?id=0a8f68226b7' target=_blank style='color:#2F92EE;'>#猴子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68226, encryptionId=0a8f68226b7, topicName=猴子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735537811831, createdName=ms1948154235210413, createdTime=Tue Mar 31 11:11:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662291, encodeId=69d5166229117, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Aug 24 17:11:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798727, encodeId=9b451e987274a, content=<a href='/topic/show?id=c23fe0014b1' target=_blank style='color:#2F92EE;'>#电化学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70014, encryptionId=c23fe0014b1, topicName=电化学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Aug 07 02:11:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775142, encodeId=db381e7514238, content=<a href='/topic/show?id=c05b43411ef' target=_blank style='color:#2F92EE;'>#多胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43411, encryptionId=c05b43411ef, topicName=多胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1538755075, createdName=waiwai3043, createdTime=Sat Apr 18 19:11:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666729, encodeId=8c9f1666e29cc, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Sep 18 11:11:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660191, encodeId=a00e16601914e, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28912, encryptionId=8d0d28912db, topicName=克隆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596825099872, createdName=aids221, createdTime=Wed Sep 25 00:11:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351272, encodeId=f1b713512e282, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87289, encryptionId=9ac28e2893e, topicName=药代动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 18 11:11:00 CST 2019, time=2019-05-18, status=1, ipAttribution=)]
    2019-08-07 kksonne
  4. [GetPortalCommentsPageByObjectIdResponse(id=1764877, encodeId=eb8a1e64877c4, content=<a href='/topic/show?id=0a8f68226b7' target=_blank style='color:#2F92EE;'>#猴子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68226, encryptionId=0a8f68226b7, topicName=猴子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735537811831, createdName=ms1948154235210413, createdTime=Tue Mar 31 11:11:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662291, encodeId=69d5166229117, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Aug 24 17:11:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798727, encodeId=9b451e987274a, content=<a href='/topic/show?id=c23fe0014b1' target=_blank style='color:#2F92EE;'>#电化学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70014, encryptionId=c23fe0014b1, topicName=电化学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Aug 07 02:11:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775142, encodeId=db381e7514238, content=<a href='/topic/show?id=c05b43411ef' target=_blank style='color:#2F92EE;'>#多胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43411, encryptionId=c05b43411ef, topicName=多胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1538755075, createdName=waiwai3043, createdTime=Sat Apr 18 19:11:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666729, encodeId=8c9f1666e29cc, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Sep 18 11:11:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660191, encodeId=a00e16601914e, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28912, encryptionId=8d0d28912db, topicName=克隆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596825099872, createdName=aids221, createdTime=Wed Sep 25 00:11:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351272, encodeId=f1b713512e282, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87289, encryptionId=9ac28e2893e, topicName=药代动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 18 11:11:00 CST 2019, time=2019-05-18, status=1, ipAttribution=)]
    2020-04-18 waiwai3043

    #多胺#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1764877, encodeId=eb8a1e64877c4, content=<a href='/topic/show?id=0a8f68226b7' target=_blank style='color:#2F92EE;'>#猴子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68226, encryptionId=0a8f68226b7, topicName=猴子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735537811831, createdName=ms1948154235210413, createdTime=Tue Mar 31 11:11:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662291, encodeId=69d5166229117, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Aug 24 17:11:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798727, encodeId=9b451e987274a, content=<a href='/topic/show?id=c23fe0014b1' target=_blank style='color:#2F92EE;'>#电化学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70014, encryptionId=c23fe0014b1, topicName=电化学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Aug 07 02:11:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775142, encodeId=db381e7514238, content=<a href='/topic/show?id=c05b43411ef' target=_blank style='color:#2F92EE;'>#多胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43411, encryptionId=c05b43411ef, topicName=多胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1538755075, createdName=waiwai3043, createdTime=Sat Apr 18 19:11:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666729, encodeId=8c9f1666e29cc, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Sep 18 11:11:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660191, encodeId=a00e16601914e, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28912, encryptionId=8d0d28912db, topicName=克隆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596825099872, createdName=aids221, createdTime=Wed Sep 25 00:11:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351272, encodeId=f1b713512e282, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87289, encryptionId=9ac28e2893e, topicName=药代动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 18 11:11:00 CST 2019, time=2019-05-18, status=1, ipAttribution=)]
    2019-09-18 fengyqf

    #药代#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1764877, encodeId=eb8a1e64877c4, content=<a href='/topic/show?id=0a8f68226b7' target=_blank style='color:#2F92EE;'>#猴子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68226, encryptionId=0a8f68226b7, topicName=猴子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735537811831, createdName=ms1948154235210413, createdTime=Tue Mar 31 11:11:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662291, encodeId=69d5166229117, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Aug 24 17:11:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798727, encodeId=9b451e987274a, content=<a href='/topic/show?id=c23fe0014b1' target=_blank style='color:#2F92EE;'>#电化学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70014, encryptionId=c23fe0014b1, topicName=电化学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Aug 07 02:11:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775142, encodeId=db381e7514238, content=<a href='/topic/show?id=c05b43411ef' target=_blank style='color:#2F92EE;'>#多胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43411, encryptionId=c05b43411ef, topicName=多胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1538755075, createdName=waiwai3043, createdTime=Sat Apr 18 19:11:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666729, encodeId=8c9f1666e29cc, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Sep 18 11:11:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660191, encodeId=a00e16601914e, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28912, encryptionId=8d0d28912db, topicName=克隆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596825099872, createdName=aids221, createdTime=Wed Sep 25 00:11:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351272, encodeId=f1b713512e282, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87289, encryptionId=9ac28e2893e, topicName=药代动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 18 11:11:00 CST 2019, time=2019-05-18, status=1, ipAttribution=)]
    2019-09-25 aids221

    #克隆#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1764877, encodeId=eb8a1e64877c4, content=<a href='/topic/show?id=0a8f68226b7' target=_blank style='color:#2F92EE;'>#猴子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68226, encryptionId=0a8f68226b7, topicName=猴子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735537811831, createdName=ms1948154235210413, createdTime=Tue Mar 31 11:11:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662291, encodeId=69d5166229117, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Aug 24 17:11:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798727, encodeId=9b451e987274a, content=<a href='/topic/show?id=c23fe0014b1' target=_blank style='color:#2F92EE;'>#电化学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70014, encryptionId=c23fe0014b1, topicName=电化学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Wed Aug 07 02:11:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775142, encodeId=db381e7514238, content=<a href='/topic/show?id=c05b43411ef' target=_blank style='color:#2F92EE;'>#多胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43411, encryptionId=c05b43411ef, topicName=多胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1538755075, createdName=waiwai3043, createdTime=Sat Apr 18 19:11:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666729, encodeId=8c9f1666e29cc, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Sep 18 11:11:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660191, encodeId=a00e16601914e, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28912, encryptionId=8d0d28912db, topicName=克隆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596825099872, createdName=aids221, createdTime=Wed Sep 25 00:11:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351272, encodeId=f1b713512e282, content=<a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87289, encryptionId=9ac28e2893e, topicName=药代动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 18 11:11:00 CST 2019, time=2019-05-18, status=1, ipAttribution=)]
    2019-05-18 zhaojie88

相关资讯

O型血是完美的血型?科学家的研究结果一出,网友又不淡定了!

说到血型决定命运,大家脑海里第一印象一定是“B型血稳重踏实”、“AB型血活泼好动”这种主观的描述。检验医学网 但最近科学家们通过长期观察和实验,发现血型决定命运是有科学依据的!甚至还选出了个“血型之王”——O型血!

空腹 VS 不空腹抽血,究竟有何区别?

尽管总是叮嘱患者空腹到医院抽血,但有时因为各种原因,可能并不能做到空腹抽血。我们这期来看一看空腹时与进食后化验检查指标的变化。 先来看看欧洲临床化学和检验学联合会(EFLM)的一篇文章中提到的各国静脉采血前空腹时间:

血液浓缩几多“稠”

前些天,我院心内一科反馈称某住院患者在行冠脉造影术前检查肾功时发现尿素(UREA)、肌酐(CRE)和尿酸(UA)结果与刚入院时结果差异较大。 本次结果为:UREA:13.76mmol/L,CRE:159μmol/L,UA:529.7mmol/L。 刚入院时结果为:UREA:7.9mmol/L,CRE:93μmol/L,UA:269.8mmol/L。

死亡真相大追击:MAHA vs AIHA,一个无法回退的生死抉择

案例经过 26日中午正准备下班时,一张外周血涂片却让我犯难了,因为在里面看到了一些“不干净”的东西,那就是红细胞碎片。尤其是在周围红细胞都正常时,它的出现就像干净的路面上突然出现的残花败叶一样显得格外刺眼。

血液中有垃圾,这个方法可以清除

众所周知,有些疾病会使我们的血液中充满“有害垃圾”,进而对机体产生病理损害,面对这种情况怎么治疗呢?要知道血液遍布全身每一个器官,这就需要输血科的帮忙,即输血治疗啦。这也是输血科工作内容的重要一环,其中治疗性血液成分置换术,是输血治疗常用的方法之一。常用的治疗性血液成分置换术有:治疗性血浆置换术和治疗性红细胞置换术。我们今天先来了解一下治疗性血浆置换术。